Structuring a New Career

Anne MacNamara In structural biology, one head may be actually better than two, because the self-sufficient scientist holds an advantage over a group, according to David Speicher, a professor at the Wistar Institute in Philadelphia. "When you obtain crystal structures of a protein, this often leads to new hypotheses," he says. "By knowing crystallography, you're not dependent on waiting on someone else to produce the new structures that you want to study." Recent technological developments th

Written byHal Cohen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In structural biology, one head may be actually better than two, because the self-sufficient scientist holds an advantage over a group, according to David Speicher, a professor at the Wistar Institute in Philadelphia. "When you obtain crystal structures of a protein, this often leads to new hypotheses," he says. "By knowing crystallography, you're not dependent on waiting on someone else to produce the new structures that you want to study."

Recent technological developments that have streamlined procedures for protein purification and production have prompted a spike in interest in structural biology over the past few years. "It's so much easier to get proteins," says Lynne Regan, professor of molecular biophysics and biochemistry at Yale University. "Protein purification is also faster so there's less time to damage it."

The potential to get more work done more rapidly prompts many scientists to learn new skills to increase their autonomy in the lab. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies